PI 3-kinase p85β siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemPI 3-kinase p85β siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-39125
Gene Namephosphoinositide-3-kinase, regulatory subunit 2 (beta)
Specieshuman
NCBI Full Gene Namephosphoinositide-3-kinase regulatory subunit 2
NCBI Gene AliasesMPPH, MPPH1, P85B, p85, p85-BETA, p85beta
TypesiRNA/dsRNA
Quantity10 µM

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Cotargeting of miR-126-3p and miR-221-3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signallingMolecular oncologyNovember 1, 2021Di Paolo D, Pontis F, Moro M, Centonze G, Bertolini G, Milione M, Mensah M, Segale M, Petraroia I, Borzi C, et al.

(2) LncRNA AK023948 is a positive regulator of AKTNature communicationsFebruary 8, 2017Koirala P, Huang J, Ho TT, Wu F, Ding X, Mo YY.purchased from Fisher Scientific (Pittsburgh, PA). DHX9 siRNAs (#sc-45706, pooled) and p85β siRNAs (#sc-39125, pooled) were purchased from Santa Cruz. Transfection of siRNAs was carried out at 50∼100 nM concentration.

(3) MiR-30a-5p Overexpression May Overcome EGFR-Inhibitor Resistance through Regulating PI3K/AKT Signaling Pathway in Non-small Cell Lung Cancer Cell LinesFrontiers in geneticsJanuary 1, 2016Meng F, Wang F, Wang L, Wong SC, Cho WC, Chan LW.

(4) γ Secretase inhibitor BMS-708163 reverses resistance to EGFR inhibitor via the PI3K/Akt pathway in lung cancerJournal of cellular biochemistryJune 1, 2015Xie M, He J, He C, Wei S.

(5) Blocking the PI3K/AKT pathway enhances mammalian reovirus replication by repressing IFN-stimulated genesFrontiers in microbiologyJanuary 1, 2015Tian J, Zhang X, Wu H, Liu C, Li Z, Hu X, Su S, Wang LF, Qu L.control sequence (sc-108060) were purchased from Santa Cruz Biotechnology. The siRNAs targeting p85α (sc-39125) and clathrin (sc-35068) were obtained from Santa Cruz Biotechnology, and the siRNA targeting FAK (6472s)

Be the First to Write a Review!